Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Human cytomegalovirus glycoprotein B (gB) is a highly conserved, type I transmembrane glycoprotein found on the envelope of human cytomegalovirus (HCMV). gB is essential for viral entry into host cells and mediates membrane fusion between the viral envelope and host cell membranes. It also plays a critical role in direct cell-to-cell spread of HCMV. As an essential mediator of viral entry/fusion, gB is considered an attractive target for antiviral drugs. Its immunogenicity makes it central to vaccine development efforts.
Inhibition of viral fusion and entry
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cytomegalovirus Glycoprotein B (gB).